New York - A single IV injection of anti-IL-12 antibody, even at low doses, resulted in significant improvement in PASI scores, according to results of a study presented at the recent International Psoriasis Symposium, held here.
Derm In The News: September 22-28
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Deuruxolitinib Shows Efficacy in Hair Regrowth, Patient Satisfaction, and Psychosocial Wellbeing in Severe Alopecia Areata
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Melinda Gooderham, MSc, MD, FRCPC: Insights Into Lebrikizumab’s Sustained 3-Year Efficacy
Positive Results Reported in Roflumilast 0.15% for AD Across Diverse Populations